BL
BLFS
BIOLIFE SOLUTIONS INC
$26.10
-1.88%
$1.3B
No data for this timeframe.
Vol
Market Cap$1.3B
Cap SizeSmall Cap
Inst. Holders50 funds
Inst. Value$511.4M
Inst. Activity12 buys / 3 sells
Insider Activity0B / 12S
Insider Net $-$30.2M
SEC Reports4
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0000834365·Prev Close $26.60
Recent Activity
Jun 8, 2026
Insider
Mathew Aby J. surrendered for taxes 627 shares
EVP & Chief Scientific Officer @ $26.10 ($16.4K)
Jun 8, 2026
Insider
Berard Todd surrendered for taxes 356 shares
Chief Marketing Officer @ $26.10 ($9.3K)
Jun 8, 2026
Insider
Wichterman Troy surrendered for taxes 1,026 shares
Chief Financial Officer @ $26.10 ($26.8K)
Jun 3, 2026
SEC
BioLife Solutions filed an 8-K furnishing an investor presentation for the Jefferies Global Healthcare Conference. The p
8-K — Impact 3/10
May 7, 2026
earnings_calendar
BLFS Q1 2026 Earnings Scheduled — 2026-05-07
Apr 28, 2026
SEC
BioLife Solutions filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, executive compensation
10-K/A — Impact 2/10
Mar 9, 2026
SEC
Multiple C-suite executives at BioLife Solutions sold shares in a coordinated cluster over the past week, with total ope
CLUSTER — Impact 6/10
Inst.
Invesco Ltd. — TRIM
2,348,532 shares ($44.8M)
Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$32.30 (Dec 2025)
Current $26.10
Low $30.00
Median $32.50
High $34.00
10 analysts
$30.00
$34.00
Analyst Ratings
4Strong Buy
11Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 29, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.06 ▲ +140.0% | $0.06 — $0.06 | 525% YoY | 1 |
| Next Q | $0.07 ▲ +75.0% | $0.07 — $0.07 | 67% YoY | 1 |
| Current FY | $0.25 ▲ +85.2% | $0.25 — $0.25 | 92% YoY | 1 |
| Next FY | $0.29 | $0.25 — $0.33 | 16% YoY | 2 |
Latest Reports
NEUTRAL
8-K
3/10
BioLife Solutions filed an 8-K furnishing an investor presentation for the Jefferies Global Healthcare Conference. The p
Jun 3, 2026
NEUTRAL
10-K/A
2/10
BioLife Solutions filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, executive compensation
Apr 28, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $116.4M | — |
| Invesco Ltd. | $44.8M | TRIM |
| VANGUARD CAPITAL MANAGEMENT LLC | $36.6M | — |
| STATE STREET CORP | $30.1M | — |
| FMR LLC | $28.1M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | Mathew Aby | F | $16.4K |
| Jun 8, 2026 | Berard Todd | F | $9.3K |
| Jun 8, 2026 | Wichterman Troy | F | $26.8K |
| May 21, 2026 | Casdin Partners | SELL | $15.4M |
| May 20, 2026 | Casdin Partners | SELL | $5.9M |
50 institutional holders with $511.4M total value (26,798,399 shares) as of 2026-Q1. Top holders: BlackRock,, Invesco, VANGUARD. Net buying activity: 12 institutions added/increased vs 3 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6,101,765 | $116.4M | 22.8% | — |
| 2 | Invesco Ltd. | 2,348,532 | $44.8M | 8.8% | TRIM -40.3% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1,917,708 | $36.6M | 7.2% | — |
| 4 | STATE STREET CORP | 1,577,076 | $30.1M | 5.9% | — |
| 5 | FMR LLC | 1,470,252 | $28.1M | 5.5% | ADD +52.4% |
| 6 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,197,257 | $22.8M | 4.5% | ADD +44.1% |
| 7 | FRED ALGER MANAGEMENT, LLC | 1,079,935 | $20.6M | 4.0% | — |
| 8 | DIMENSIONAL FUND ADVISORS LP | 1,035,757 | $19.8M | 3.9% | — |
| 9 | BANK OF AMERICA CORP /DE/ | 904,103 | $17.3M | 3.4% | ADD +73.4% |
| 10 | AMERIPRISE FINANCIAL INC | 901,138 | $17.2M | 3.4% | — |
| 11 | ROYAL BANK OF CANADA | 885,298 | $16.9M | 3.3% | — |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLC | 865,038 | $16.5M | 3.2% | — |
| 13 | Rockefeller Capital Management L.P. | 741,352 | $14.1M | 2.8% | TRIM -30.1% |
| 14 | ROYCE & ASSOCIATES LP | 584,011 | $11.1M | 2.2% | ADD +40.0% |
| 15 | MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 572,729 | $10.9M | 2.1% | — |
| 16 | MORGAN STANLEY | 444,228 | $8.5M | 1.7% | — |
| 17 | RAYMOND JAMES FINANCIAL INC | 444,041 | $8.4M | 1.6% | — |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 403,485 | $7.7M | 1.5% | — |
| 19 | VANGUARD FIDUCIARY TRUST CO | 278,730 | $5.3M | 1.0% | — |
| 20 | Russell Investments Group, Ltd. | 268,225 | $5.1M | 1.0% | ADD +61.4% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Invesco Ltd. | TRIM | 3,932,191 | 2,348,532 | -40.3% | $44.8M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 521,327 | 904,103 | +73.4% | $17.3M | 2026-Q1 |
| ROYCE & ASSOCIATES LP | ADD | 417,090 | 584,011 | +40.0% | $11.1M | 2026-Q1 |
| Russell Investments Group, Ltd. | ADD | 166,229 | 268,225 | +61.4% | $5.1M | 2026-Q1 |
| Cerity Partners LLC | ADD | 44,446 | 57,483 | +29.3% | $1.1M | 2026-Q1 |
| STIFEL FINANCIAL CORP | ADD | 16,433 | 20,594 | +25.3% | $392.9K | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 402 | 16,101 | +3905.2% | $307.2K | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | DOUBLED | 211 | 13,991 | +6530.8% | $266.9K | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 19,221 | 11,401 | -40.7% | $217.5K | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | ADD | 700 | 1,007 | +43.9% | $19.2K | 2026-Q1 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | DOUBLED | 837 | 15,659 | +1770.8% | $15.9K | 2026-Q1 |
| CWM, LLC | ADD | 139 | 205 | +47.5% | $3.9K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 54 | 112 | +107.4% | $2.1K | 2026-Q1 |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 29,783 | 40,295 | +35.3% | $769.00 | 2026-Q1 |
| VOYA INVESTMENT MANAGEMENT LLC | EXIT | 496,937 | 0 | -100.0% | $0.00 | 2026-Q1 |
| FMR LLC | ADD | 1,015,771 | 1,548,194 | +52.4% | $37.4M | 2025-Q4 |
| Rockefeller Capital Management L.P. | TRIM | 1,010,129 | 705,863 | -30.1% | $17.1M | 2025-Q4 |
| D. E. Shaw & Co., Inc. | TRIM | 285,543 | 166,381 | -41.7% | $4.0M | 2025-Q4 |
| Nuveen, LLC | ADD | 66,843 | 111,956 | +67.5% | $2.7M | 2025-Q4 |
| ALLIANCEBERNSTEIN L.P. | ADD | 33,250 | 44,012 | +32.4% | $1.1M | 2025-Q4 |
| Allspring Global Investments Holdings, LLC | TRIM | 79,719 | 24,622 | -69.1% | $595.4K | 2025-Q4 |
| PNC FINANCIAL SERVICES GROUP, INC. | TRIM | 4,425 | 2,668 | -39.7% | $64.5K | 2025-Q4 |
| BNP Paribas Asset Management Holding S.A. | ADD | 491 | 700 | +42.6% | $17.00 | 2025-Q4 |
| FMR LLC | DOUBLED | 3,081 | 1,015,771 | +32868.9% | $25.9M | 2025-Q3 |
| Rockefeller Capital Management L.P. | DOUBLED | 74,134 | 1,010,129 | +1262.6% | $25.8M | 2025-Q3 |
14 unique insiders with 38 transactions. Net insider value: -$30.2M ($0.00 bought, $30.2M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Mathew Aby J. | EVP & Chief Scientific Officer | TAX W/H | 627 | $26.10 | $16.4K |
| Jun 8, 2026 | Berard Todd | Chief Marketing Officer | TAX W/H | 356 | $26.10 | $9.3K |
| Jun 8, 2026 | Wichterman Troy | Chief Financial Officer | TAX W/H | 1,026 | $26.10 | $26.8K |
| May 21, 2026 | Casdin Partners Master Fund, L.P. | 10%+ Owner | SELL | 650,000 | $23.70 | $15.4M |
| May 20, 2026 | Casdin Partners Master Fund, L.P. | 10%+ Owner | SELL | 250,000 | $23.70 | $5.9M |
| May 19, 2026 | Casdin Partners Master Fund, L.P. | 10%+ Owner | SELL | 300,000 | $22.65 | $6.8M |
| Apr 8, 2026 | Wichterman Troy | Chief Financial Officer | TAX W/H | 844 | $19.27 | $16.3K |
| Apr 8, 2026 | Berard Todd | Chief Marketing Officer | TAX W/H | 293 | $19.27 | $5.6K |
| Apr 8, 2026 | Mathew Aby J. | EVP & Chief Scientific Officer | TAX W/H | 515 | $19.27 | $9.9K |
| Mar 23, 2026 | Foster Karen A. | Chief Quality and Operations | SELL | 2,577 | $19.17 | $49.4K |
| Mar 19, 2026 | Wichterman Troy | Chief Financial Officer | TAX W/H | 3,749 | $19.12 | $71.7K |
| Mar 19, 2026 | Foster Karen A. | Chief Quality and Operations | TAX W/H | 1,907 | $19.12 | $36.5K |
| Mar 19, 2026 | Berard Todd | Chief Marketing Officer | TAX W/H | 1,879 | $19.12 | $35.9K |
| Mar 19, 2026 | Werner Sean | Chief Technology Officer | TAX W/H | 1,681 | $19.12 | $32.1K |
| Mar 19, 2026 | Mathew Aby J. | EVP & Chief Scientific Officer | TAX W/H | 2,255 | $19.12 | $43.1K |
| Mar 19, 2026 | Aebersold Sarah | Chief Human Resources Officer | TAX W/H | 931 | $19.12 | $17.8K |
| Mar 19, 2026 | DE GREEF RODERICK | President and CEO | TAX W/H | 11,101 | $19.12 | $212.3K |
| Mar 9, 2026 | Foster Karen A. | Chief Quality and Operations | SELL | 500 | $20.00 | $10.0K |
| Mar 5, 2026 | Foster Karen A. | Chief Quality and Operations | SELL | 96,923 | $20.15 | $2.0M |
| Mar 3, 2026 | Aebersold Sarah | Chief Human Resources Officer | SELL | 219 | $20.74 | $4.5K |
| Mar 3, 2026 | Berard Todd | Chief Marketing Officer | SELL | 353 | $20.74 | $7.3K |
| Mar 3, 2026 | Werner Sean | Chief Technology Officer | SELL | 111 | $20.74 | $2.3K |
| Mar 3, 2026 | Mathew Aby J. | EVP & Chief Scientific Officer | SELL | 529 | $20.74 | $11.0K |
| Mar 3, 2026 | Foster Karen A. | Chief Quality and Operations | SELL | 418 | $20.74 | $8.7K |
| Mar 3, 2026 | Wichterman Troy | Chief Financial Officer | SELL | 588 | $20.74 | $12.2K |
| Feb 24, 2026 | Berard Todd | Chief Marketing Officer | AWARD | 20,096 | — | — |
| Feb 24, 2026 | Foster Karen A. | Chief Quality and Operations | AWARD | 32,112 | — | — |
| Feb 24, 2026 | GOSWAMI JOYDEEP | Director | AWARD | 8,170 | — | — |
| Feb 24, 2026 | DuRoss Amy | Director | AWARD | 8,170 | — | — |
| Feb 24, 2026 | Werner Sean | Chief Technology Officer | AWARD | 24,116 | — | — |
| Feb 24, 2026 | Coste Catherine | Director | AWARD | 8,170 | — | — |
| Feb 24, 2026 | Hunt Anthony | Director | AWARD | 8,170 | — | — |
| Feb 24, 2026 | Ellingson Rachel | Director | AWARD | 8,170 | — | — |
| Feb 24, 2026 | Wichterman Troy | Chief Financial Officer | AWARD | 31,150 | — | — |
| Feb 24, 2026 | DE GREEF RODERICK | President and CEO | AWARD | 118,730 | — | — |
| Feb 24, 2026 | Mathew Aby J. | EVP & Chief Scientific Officer | AWARD | 20,096 | — | — |
| Feb 24, 2026 | Aebersold Sarah | Chief Human Resources Officer | AWARD | 23,548 | — | — |
| Feb 24, 2026 | MOORE TIMOTHY L. | Director | AWARD | 8,170 | — | — |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 3 neutral. Avg impact: 3.5/10.
NEUTRAL
8-K
3/10
BioLife Solutions filed an 8-K furnishing an investor presentation for the Jefferies Global Healthca
Jun 3, 2026
NEUTRAL
10-K/A
2/10
BioLife Solutions filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, ex
Apr 28, 2026
BEARISH
CLUSTER
6/10
Multiple C-suite executives at BioLife Solutions sold shares in a coordinated cluster over the past
Mar 9, 2026
NEUTRAL
CLUSTER
3/10
Four C-suite executives at BioLife Solutions — including the CFO and Chief Quality and Operations Of
Mar 5, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2025): 94% buy across 16 analysts — 4 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$32.30 mean target (Dec 2025)
$30.00 Low
$34.00 High
| Metric | Value |
|---|---|
| Current Price | $26.10 |
| Target Low | $30.00 |
| Target Mean | $32.30 |
| Target Median | $32.50 |
| Target High | $34.00 |
| # Analysts | 10 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.06 | $0.06 | $0.06 | 525.0% | +140.0% | — | $0.0B | 8.2% | 1 |
| Next Q 2026-09-30 |
$0.07 | $0.07 | $0.07 | 66.9% | +75.0% | — | $0.0B | 3.5% | 1 |
| Current FY 2026-12-31 |
$0.25 | $0.25 | $0.25 | 91.9% | +85.2% | 0↑ 1↓ | $0.1B | 18.2% | 1 |
| Next FY 2027-12-31 |
$0.29 | $0.25 | $0.33 | 16.0% | +0.0% | 1↑ 0↓ | $0.1B | 17.9% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.060 | |
| 7d ago | $0.025 | +0.035 |
| 30d ago | $0.025 | +0.035 |
| 60d ago | $0.025 | +0.035 |
| 90d ago | $0.020 | +0.040 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 29, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 11 | 1 | 0 | 0 | 94% | |
| May 1, 2026 | 4 | 11 | 1 | 0 | 0 | 94% | |
| Apr 1, 2026 | 4 | 11 | 1 | 0 | 0 | 94% | |
| Mar 1, 2026 | 4 | 11 | 1 | 0 | 0 | 94% | |
| Feb 1, 2026 | 4 | 11 | 1 | 0 | 0 | 94% | |
| Jan 1, 2026 | 4 | 11 | 1 | 0 | 0 | 94% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 7, 2026
earnings_calendar
BLFS Q1 2026 Earnings Scheduled — 2026-05-07
Feb 26, 2026
earnings_calendar
BLFS Q4 2025 Earnings After Market Close — 2026-02-26